This has been demonstrated by an impaired ability of CD8+ T cells to secrete IFN-γ, thus hampering the lysing of tumor cells in human HCC with different etiologies, including NAFLD [180]. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.